The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 17,390 | 4,588,352 | SH | SOLE | 4,588,352 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 80,597 | 1,696,773 | SH | SOLE | 1,696,773 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 11,716 | 1,430,579 | SH | SOLE | 1,430,579 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 228,173 | 10,990,975 | SH | SOLE | 10,990,975 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 10,083 | 142,943 | SH | SOLE | 142,943 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 27,447 | 4,222,558 | SH | SOLE | 4,222,558 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 91,166 | 17,875,655 | SH | SOLE | 17,875,655 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 23,150 | 1,666,667 | SH | SOLE | 1,666,667 | 0 | 0 | ||
| CORCEPT THERAPEUTICS INC | COM | 218352102 | 43,995 | 3,747,453 | SH | SOLE | 3,747,453 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 43,096 | 3,478,261 | SH | SOLE | 3,478,261 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 2,785 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 10,841 | 1,140,000 | SH | SOLE | 1,140,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 30,698 | 11,627,900 | SH | SOLE | 11,627,900 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 30,128 | 5,158,884 | SH | SOLE | 5,158,884 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 109,866 | 3,309,206 | SH | SOLE | 3,309,206 | 0 | 0 | ||
| OMEROS CORP | COM | 682143102 | 36,905 | 2,124,619 | SH | SOLE | 2,124,619 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 44,949 | 2,608,784 | SH | SOLE | 2,608,784 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | COM | 695127100 | 139,000 | 3,652,134 | SH | SOLE | 3,652,134 | 0 | 0 | ||
| RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 7,503 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 91,247 | 4,032,123 | SH | SOLE | 4,032,123 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 22,800 | 3,093,690 | SH | SOLE | 3,093,690 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 118,433 | 1,985,460 | SH | SOLE | 1,985,460 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 143,824 | 1,225,387 | SH | SOLE | 1,225,387 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 64,989 | 1,759,324 | SH | SOLE | 1,759,324 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 78,354 | 4,258,358 | SH | SOLE | 4,258,358 | 0 | 0 | ||
| VERICEL CORP | COM | 92346J108 | 75,084 | 4,288,092 | SH | SOLE | 4,288,092 | 0 | 0 | ||